524 biotech jobs found in Berkeley, CA

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

Established in 2006 by the merger of two 100-year-old Japanese pharmaceutical companies, Daiichi Sankyo, Inc. is headquartered in New Jersey. The organization includes U.S. commercial operations and global drug development. We offer a unique blend of an entrepreneurial environment and a collaborative culture, and the innovation that propels us forward comes from all corners of our company. At Daiichi Sankyo, good ideas don't just happen in the lab, but also in conference rooms, at desks and in the field, contributed both by individuals and groups.

As a worldwide workforce we are deeply committed to helping solve some of today’s biggest healthcare challenges, offering solutions for patients suffering from life-threatening diseases such as HIV/AIDS, liver disease, oncology and respiratory disease. At our core lies a corporate culture committed to science and patients, and an employee environment that fosters innovation, diversity and a commitment to the personal and professional development of all our colleagues. As we grow, we are continually looking to connect with outstanding individuals who are interested in joining our intellectually stimulating and socially responsible team. Successful colleagues at Gilead come from all backgrounds, have a range of perspectives and thrive in an agile and rapidly evolving environment.

As a worldwide workforce we are deeply committed to helping solve some of today’s biggest healthcare challenges, offering solutions for patients suffering from life-threatening diseases such as HIV/AIDS, liver disease, oncology and respiratory disease. At our core lies a corporate culture committed to science and patients, and an employee environment that fosters innovation, diversity and a commitment to the personal and professional development of all our colleagues. As we grow, we are continually looking to connect with outstanding individuals who are interested in joining our intellectually stimulating and socially responsible team. Successful colleagues at Gilead come from all backgrounds, have a range of perspectives and thrive in an agile and rapidly evolving environment.

As a worldwide workforce we are deeply committed to helping solve some of today’s biggest healthcare challenges, offering solutions for patients suffering from life-threatening diseases such as HIV/AIDS, liver disease, oncology and respiratory disease. At our core lies a corporate culture committed to science and patients, and an employee environment that fosters innovation, diversity and a commitment to the personal and professional development of all our colleagues. As we grow, we are continually looking to connect with outstanding individuals who are interested in joining our intellectually stimulating and socially responsible team. Successful colleagues at Gilead come from all backgrounds, have a range of perspectives and thrive in an agile and rapidly evolving environment.

As a worldwide workforce we are deeply committed to helping solve some of today’s biggest healthcare challenges, offering solutions for patients suffering from life-threatening diseases such as HIV/AIDS, liver disease, oncology and respiratory disease. At our core lies a corporate culture committed to science and patients, and an employee environment that fosters innovation, diversity and a commitment to the personal and professional development of all our colleagues. As we grow, we are continually looking to connect with outstanding individuals who are interested in joining our intellectually stimulating and socially responsible team. Successful colleagues at Gilead come from all backgrounds, have a range of perspectives and thrive in an agile and rapidly evolving environment.

We have a strong patient-focused cul​​​​​​​ture at Jazz Pharmaceuticals that our employees believe in and pursue every day. It is clearly identified through our mission, vision and core values.

We have a strong patient-focused cul​​​​​​​ture at Jazz Pharmaceuticals that our employees believe in and pursue every day. It is clearly identified through our mission, vision and core values.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.